The Manufacturers Life Insurance Company Buys 5,366 Shares of Agilent Technologies Inc (A)

The Manufacturers Life Insurance Company boosted its holdings in shares of Agilent Technologies Inc (NYSE:A) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 348,029 shares of the medical research company’s stock after purchasing an additional 5,366 shares during the period. The Manufacturers Life Insurance Company owned about 0.11% of Agilent Technologies worth $23,307,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in A. Robeco Institutional Asset Management B.V. increased its holdings in Agilent Technologies by 124.0% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 127,608 shares of the medical research company’s stock valued at $8,193,000 after purchasing an additional 70,639 shares during the period. Fisher Asset Management LLC purchased a new position in Agilent Technologies during the 3rd quarter valued at about $609,000. APG Asset Management N.V. increased its holdings in Agilent Technologies by 5.0% during the 3rd quarter. APG Asset Management N.V. now owns 481,454 shares of the medical research company’s stock valued at $30,909,000 after purchasing an additional 22,800 shares during the period. Fox Run Management L.L.C. purchased a new position in Agilent Technologies during the 3rd quarter valued at about $437,000. Finally, Nationwide Fund Advisors increased its holdings in Agilent Technologies by 132.5% during the 3rd quarter. Nationwide Fund Advisors now owns 575,282 shares of the medical research company’s stock valued at $36,933,000 after purchasing an additional 327,822 shares during the period.

A number of research firms have weighed in on A. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Deutsche Bank set a $75.00 target price on Agilent Technologies and gave the stock a “buy” rating in a report on Tuesday, November 21st. Cowen reiterated a “hold” rating and set a $70.00 target price on shares of Agilent Technologies in a report on Wednesday, November 22nd. Barclays upped their target price on Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a report on Tuesday, November 21st. Finally, JPMorgan Chase & Co. upped their target price on Agilent Technologies to $75.00 and gave the stock an “overweight” rating in a report on Tuesday, November 21st. Five investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Agilent Technologies presently has an average rating of “Buy” and a consensus target price of $70.98.

In related news, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $69.56, for a total value of $347,800.00. Following the transaction, the insider now directly owns 75,504 shares of the company’s stock, valued at approximately $5,252,058.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Mark Doak sold 4,154 shares of the company’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total value of $278,318.00. Following the completion of the transaction, the vice president now directly owns 68,270 shares in the company, valued at $4,574,090. The disclosure for this sale can be found here. Insiders sold a total of 154,707 shares of company stock worth $10,944,828 in the last 90 days.

Shares of Agilent Technologies Inc (NYSE A) opened at $70.70 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.23 and a quick ratio of 2.78. The firm has a market capitalization of $22,809.66, a P/E ratio of 28.27, a P/E/G ratio of 2.37 and a beta of 1.28. Agilent Technologies Inc has a 52 week low of $50.86 and a 52 week high of $75.00.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.08. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same quarter in the prior year, the business posted $0.53 EPS. analysts forecast that Agilent Technologies Inc will post 2.67 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Week Herald and is owned by of Week Herald. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://weekherald.com/2018/02/24/the-manufacturers-life-insurance-company-buys-5366-shares-of-agilent-technologies-inc-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply